Servier and MBC BioLabs Announce the Winner of the 2019 Servier Golden Ticket

Servier and MBC BioLabs announced that the 2019 Servier Golden Ticket at MBC BioLabs has been awarded to Quartz Therapeutics, a California-based biotech. The award will help Quartz Therapeutics continue its breakthrough work developing effective therapies for RAS oncogene-driven cancers. Full Press Release.
Lunch Seminar with WSGR:
Patenting in the Microbiome/Natural Products Space

June 11, 2019
12:00 to 1:00 PM

MBC BioLabs - 953 Indiana Street, San Francisco
Lunch served

Maya Skubatch is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she focuses on strategic patent counseling for healthcare and other technology driven companies. She represents both private and public companies and works closely with licensing, litigation, corporate, and regulatory counsel to provide her clients with a holistic IP strategy. Her strategic counseling includes developing a comprehensive IP strategy for early-stage companies that maximizes patent protection for their lead products in light of their product development timelines and positioning them for successful exits. Maya assists clients with IP matters pertaining to financings, M&A, and partnership deals. She also helps companies and investors in IP due diligence.

 Founders at Work Speaker Series
Mattershift: Building Matter from Molecular Parts
June 19, 2019
12:30 to 1:30 PM

MBC BioLabs - 953 Indiana Street, San Francisco
Lunch served

Rob McGinnis, PhD, is an inventor and entrepreneur. He is the Founder and CEO of Prometheus, a Silicon Valley-based tech startup that removes carbon dioxide from the air and turns it into gasoline, diesel, and jet fuels that are zero-net-carbon and compete with fossil fuels on performance and price. He previously founded Mattershift, which launched the Prometheus technology platform and continues to develop scalable molecular factories for the production of fuels, fertilizers, chemicals, medicines, and materials from molecular building blocks. Rob invented the first practical and scalable Carbon Nanotube (CNT) membrane, as well as the first hollow fiber CNT membrane.

Larger Than Life Science:
Critical Cash
June 26, 2019
4:00 to 7:00 PM

MBC BioLabs - 953 Indiana Street, San Francisco
Drinks and appetizers served 

Larger Than Life Science is a free monthly event series open to everyone interested in building a strong support network for San Diego's life science and healthcare innovators.

This month's theme: Critical Cash

Non-dilutive funding is any kind of financing that does not require giving up ownership of the company. Biotech and life science startups often rely on government industry grants, including the Small Business Innovation Research (SBIR) and Technology Transfer (STTR) programs, which are designed to enable the commercialization of cutting-edge technologies. Other sources of non-dilutive funding include foundations, industry partnerships, and venture debt.

While these can be important sources of cash, non-dilutive funds are not "free" and can have some unintended consequences and costs. Join us to hear a variety of perspectives – entrepreneur, investor, entrepreneurial support organization and legal expert –to learn how to secure and deploy this type of "critical cash."
Come for the people and programs. Stay for a beer. Leave with your next big breakthrough!